Table of Content

1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Overview
1.1 Receptor Tyrosine Protein Kinase Targeted Drugs Product Overview
1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Market Segment by Type
1.2.1 Afatinib Dimaleate
1.2.2 Dacomitinib
1.2.3 Neratinib
1.2.4 Neucardin
1.2.5 Others
1.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Type
1.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2018-2024)
2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Competition by Company
2.1 Global Top Players by Receptor Tyrosine Protein Kinase Targeted Drugs Sales (2018-2024)
2.2 Global Top Players by Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (2018-2024)
2.3 Global Top Players by Receptor Tyrosine Protein Kinase Targeted Drugs Price (2018-2024)
2.4 Global Top Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Receptor Tyrosine Protein Kinase Targeted Drugs Market Competitive Situation and Trends
2.5.1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Receptor Tyrosine Protein Kinase Targeted Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase Targeted Drugs Market
2.8 Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Receptor Tyrosine Protein Kinase Targeted Drugs Status and Outlook by Region
3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Region
3.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Region
3.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Receptor Tyrosine Protein Kinase Targeted Drugs by Application
4.1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Segment by Application
4.1.1 Oncology
4.1.2 Cardiovascular
4.1.3 Central Nervous System
4.1.4 Others
4.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Application
4.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2018-2024)
5 North America Receptor Tyrosine Protein Kinase Targeted Drugs by Country
5.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Country
5.1.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2018-2024)
5.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Country
5.2.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2024-2034)
6 Europe Receptor Tyrosine Protein Kinase Targeted Drugs by Country
6.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Country
6.1.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2018-2024)
6.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Country
6.2.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs by Region
7.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Region (2024-2034)
8 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs by Country
8.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Country
8.1.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Country
8.2.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs by Country
9.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Aslan Pharmaceuticals Pte Ltd
10.1.1 Aslan Pharmaceuticals Pte Ltd Company Information
10.1.2 Aslan Pharmaceuticals Pte Ltd Introduction and Business Overview
10.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.1.5 Aslan Pharmaceuticals Pte Ltd Recent Development
10.2 Boehringer Ingelheim GmbH
10.2.1 Boehringer Ingelheim GmbH Company Information
10.2.2 Boehringer Ingelheim GmbH Introduction and Business Overview
10.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.2.5 Boehringer Ingelheim GmbH Recent Development
10.3 GamaMabs Pharma SA
10.3.1 GamaMabs Pharma SA Company Information
10.3.2 GamaMabs Pharma SA Introduction and Business Overview
10.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.3.5 GamaMabs Pharma SA Recent Development
10.4 Hanmi Pharmaceuticals Co Ltd
10.4.1 Hanmi Pharmaceuticals Co Ltd Company Information
10.4.2 Hanmi Pharmaceuticals Co Ltd Introduction and Business Overview
10.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.4.5 Hanmi Pharmaceuticals Co Ltd Recent Development
10.5 Jiangsu Kanion Pharmaceutical Co Ltd
10.5.1 Jiangsu Kanion Pharmaceutical Co Ltd Company Information
10.5.2 Jiangsu Kanion Pharmaceutical Co Ltd Introduction and Business Overview
10.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.5.5 Jiangsu Kanion Pharmaceutical Co Ltd Recent Development
10.6 Minerva Neurosciences Inc
10.6.1 Minerva Neurosciences Inc Company Information
10.6.2 Minerva Neurosciences Inc Introduction and Business Overview
10.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.6.5 Minerva Neurosciences Inc Recent Development
10.7 Pfizer Inc
10.7.1 Pfizer Inc Company Information
10.7.2 Pfizer Inc Introduction and Business Overview
10.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.7.5 Pfizer Inc Recent Development
10.8 Puma Biotechnology Inc
10.8.1 Puma Biotechnology Inc Company Information
10.8.2 Puma Biotechnology Inc Introduction and Business Overview
10.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.8.5 Puma Biotechnology Inc Recent Development
10.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
10.9.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Information
10.9.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Introduction and Business Overview
10.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.9.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Development
10.10 XuanZhu Pharma Co Ltd
10.10.1 XuanZhu Pharma Co Ltd Company Information
10.10.2 XuanZhu Pharma Co Ltd Introduction and Business Overview
10.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.10.5 XuanZhu Pharma Co Ltd Recent Development
10.11 Zensun (Shanghai) Sci & Tech Co Ltd
10.11.1 Zensun (Shanghai) Sci & Tech Co Ltd Company Information
10.11.2 Zensun (Shanghai) Sci & Tech Co Ltd Introduction and Business Overview
10.11.3 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered
10.11.5 Zensun (Shanghai) Sci & Tech Co Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Receptor Tyrosine Protein Kinase Targeted Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
11.4 Receptor Tyrosine Protein Kinase Targeted Drugs Market Dynamics
11.4.1 Receptor Tyrosine Protein Kinase Targeted Drugs Industry Trends
11.4.2 Receptor Tyrosine Protein Kinase Targeted Drugs Market Drivers
11.4.3 Receptor Tyrosine Protein Kinase Targeted Drugs Market Challenges
11.4.4 Receptor Tyrosine Protein Kinase Targeted Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Receptor Tyrosine Protein Kinase Targeted Drugs Distributors
12.3 Receptor Tyrosine Protein Kinase Targeted Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Afatinib Dimaleate
Table 2. Major Company of Dacomitinib
Table 3. Major Company of Neratinib
Table 4. Major Company of Neucardin
Table 5. Major Company of Others
Table 6. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2018-2024) & (US& Million)
Table 10. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share in Value by Type (2018-2024)
Table 11. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type (2024-2034)
Table 16. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Company (2018-2024)
Table 29. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Company (2018-2024)
Table 31. Global Market Receptor Tyrosine Protein Kinase Targeted Drugs Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Receptor Tyrosine Protein Kinase Targeted Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Receptor Tyrosine Protein Kinase Targeted Drugs as of 2022)
Table 35. Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase Targeted Drugs Market
Table 36. Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Region (2018-2024)
Table 43. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Region (2024-2034)
Table 48. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application (2018-2024)
Table 54. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application (2024-2034)
Table 59. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2018-2024) (K Pcs)
Table 61. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2018-2024)
Table 74. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2024-2034)
Table 110. Aslan Pharmaceuticals Pte Ltd Company Information
Table 111. Aslan Pharmaceuticals Pte Ltd Introduction and Business Overview
Table 112. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 114. Aslan Pharmaceuticals Pte Ltd Recent Development
Table 115. Boehringer Ingelheim GmbH Company Information
Table 116. Boehringer Ingelheim GmbH Introduction and Business Overview
Table 117. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 119. Boehringer Ingelheim GmbH Recent Development
Table 120. GamaMabs Pharma SA Company Information
Table 121. GamaMabs Pharma SA Introduction and Business Overview
Table 122. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 124. GamaMabs Pharma SA Recent Development
Table 125. Hanmi Pharmaceuticals Co Ltd Company Information
Table 126. Hanmi Pharmaceuticals Co Ltd Introduction and Business Overview
Table 127. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 129. Hanmi Pharmaceuticals Co Ltd Recent Development
Table 130. Jiangsu Kanion Pharmaceutical Co Ltd Company Information
Table 131. Jiangsu Kanion Pharmaceutical Co Ltd Introduction and Business Overview
Table 132. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 134. Jiangsu Kanion Pharmaceutical Co Ltd Recent Development
Table 135. Minerva Neurosciences Inc Company Information
Table 136. Minerva Neurosciences Inc Introduction and Business Overview
Table 137. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 139. Minerva Neurosciences Inc Recent Development
Table 140. Pfizer Inc Company Information
Table 141. Pfizer Inc Introduction and Business Overview
Table 142. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 144. Pfizer Inc Recent Development
Table 145. Puma Biotechnology Inc Company Information
Table 146. Puma Biotechnology Inc Introduction and Business Overview
Table 147. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 149. Puma Biotechnology Inc Recent Development
Table 150. Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Information
Table 151. Shanghai Fosun Pharmaceutical (Group) Co Ltd Introduction and Business Overview
Table 152. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 154. Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Development
Table 155. XuanZhu Pharma Co Ltd Company Information
Table 156. XuanZhu Pharma Co Ltd Introduction and Business Overview
Table 157. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 159. XuanZhu Pharma Co Ltd Recent Development
Table 160. Zensun (Shanghai) Sci & Tech Co Ltd Company Information
Table 161. Zensun (Shanghai) Sci & Tech Co Ltd Introduction and Business Overview
Table 162. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 163. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 164. Zensun (Shanghai) Sci & Tech Co Ltd Recent Development
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Receptor Tyrosine Protein Kinase Targeted Drugs Market Trends
Table 168. Receptor Tyrosine Protein Kinase Targeted Drugs Market Drivers
Table 169. Receptor Tyrosine Protein Kinase Targeted Drugs Market Challenges
Table 170. Receptor Tyrosine Protein Kinase Targeted Drugs Market Restraints
Table 171. Receptor Tyrosine Protein Kinase Targeted Drugs Distributors List
Table 172. Receptor Tyrosine Protein Kinase Targeted Drugs Downstream Customers
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Receptor Tyrosine Protein Kinase Targeted Drugs Product Picture
Figure 2. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Afatinib Dimaleate
Figure 6. Global Afatinib Dimaleate Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Dacomitinib
Figure 8. Global Dacomitinib Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Neratinib
Figure 10. Global Neratinib Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Neucardin
Figure 12. Global Neucardin Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type in 2022 & 2034
Figure 17. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2022
Figure 18. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2022
Figure 19. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2022
Figure 23. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Receptor Tyrosine Protein Kinase Targeted Drugs Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Receptor Tyrosine Protein Kinase Targeted Drugs Revenue in 2022
Figure 29. Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Oncology
Figure 31. Global Oncology Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Cardiovascular
Figure 33. Global Cardiovascular Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Central Nervous System
Figure 35. Global Central Nervous System Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application in 2022 & 2034
Figure 40. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application in 2022
Figure 41. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2022
Figure 42. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2022
Figure 46. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Cost Structure
Figure 51. Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed